Duke NUS Medical School
Singapore
Location status: Recruiting
NCT Number: NCT07309367
'My Voice' is a website intervention developed to enable advance care planning (ACP) conversations for patients with kidney disease on dialysis, educate patients on their illness, help identify their goals and preferences for EOL care, and coaches them on how to speak with their HCPs and loved ones. This study aims to evaluate if 'My Voice' intervention improves quality of ACP conversations between patients and providers, and patients and family carers; improves patient's knowledge about kidney failure, engagement in ACP and preparedness for future end of life care compared to usual practices for ACP in dialysis centres.
Interested in participating?
Request Info21 year and older
All sexes
Interventional
Not applicable
Singapore
Location status: Recruiting
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
For patients
Inclusion criteria
For caregivers
Exclusion criteria
For Patients
Exclusion criteria
For Caregivers
'My Voice' is an interactive web-based ACP intervention tailored for patients with kidney failure on dialysis, and their caregivers, and includes patient and caregiver modules. Patient module has 6 steps consisting of a series of videos, value-clarification exercise (VCE) identifying goals and values for care, and knowledge quiz, and a summary My Voice document that is generated shared with patients, designated surrogates and HCPs. Automated reminders are sent to revisit My Voice. Caregiver module has 4 steps with videos and quiz, with access to their loved one's summary My Voice document containing goals of care and values.
Time frame: Post baseline and within 8 weeks
Quality of ACP conversations will be measured using a scoring sheet developed for the study. One point will be given for every SICG topic discussed with score min to max of 0 to 13. Higher scores indicate higher quality.
Time frame: Baseline to 8 weeks
Collected using knowledge questions designed by the research team. Higher scores indicate higher knowledge
Time frame: Baseline to 8 weeks
Using the 9-item Advance care planning engagement scale. 9 to 45 (Min to Max) value, with higher value indicating higher engagement
Time frame: Baseline to 8 weeks
Assessed using Preparedness for end-of-life decision-making scale. 20 to 80 (min to max) scores, with higher scores indicating better preparedness
Time frame: Baseline and 8 weeks
Based on self-reported number of ACP conversations collected in the survey
Contact information is provided by the study sponsor or research team.
Duke-NUS Graduate Medical School
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01920854
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Kalamazoo, Michigan, United States
View Trial DetailsNCT06972069
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Boston, Massachusetts, United States
View Trial DetailsNCT07348237
Chronic Disease, Chronic Kidney Failure
Miami Lakes, Florida, United States
View Trial DetailsNCT07550790
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Seongnam-si, Gyeonggi-do, South Korea
View Trial Details